Efficacy of Rifampin-Moxifloxacin-Metronidazole Combination Therapy in Hidradenitis Suppurativa - Institut Pasteur Access content directly
Journal Articles Dermatology Year : 2011

Efficacy of Rifampin-Moxifloxacin-Metronidazole Combination Therapy in Hidradenitis Suppurativa

Hélène Guet-Revillet
  • Function : Author
  • PersonId : 780149
  • IdRef : 142993867
Sylvie Behillil
Xavier Nassif
Aude Nassif
  • Function : Author
  • PersonId : 1068311

Abstract

Background: Antibiotics have been shown to improve hidradenitis suppurativa (HS) patients but complete remission is rare using these treatments. Objective: To assess the efficacy and safety of a combination of oral rifampin, moxifloxacin and metronidazole in long-lasting refractory HS. Methods: We retrospectively studied 28 consecutive HS patients including 6, 10 and 12 Hurley stage 1, 2 and 3 patients, respectively. Complete remission, defined as a clearance of all inflammatory lesions including hypertrophic scars, was the main outcome criterion of the study. Results: Complete remission was obtained in 16 patients, including 6/6, 8/10 and 2/12 patients with Hurley stage 1, 2 and 3, respectively (p=0.0004). The median duration of treatment to obtain complete remission was 2.4 (range 0.9-6.5) and 3.8 months (range 1.6-7.4) in stage 1 and 2 patients, respectively, and 6.2 and 12 months in the 2 stage 3 patients. Main adverse events of the treatments were gastrointestinal disorders (64% of patients) and vaginal candidiasis (35% of females). Reversible tendinopathy and hepatitis occurred in 4 and 1 patient, respectively. Conclusions: Complete remission of refractory HS can be obtained using broad-spectrum antibiotics and Hurley staging is a prognostic factor of response to the treatment.
No file

Dates and versions

pasteur-02572642 , version 1 (13-05-2020)

Identifiers

Cite

Olivier Join-Lambert, Hélène Coignard, Jean-Philippe Jais, Hélène Guet-Revillet, Sylvain Poirée, et al.. Efficacy of Rifampin-Moxifloxacin-Metronidazole Combination Therapy in Hidradenitis Suppurativa. Dermatology, 2011, 222 (1), pp.49-58. ⟨10.1159/000321716⟩. ⟨pasteur-02572642⟩

Collections

PASTEUR CNRS
28 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More